Literature DB >> 25613924

Improving accuracy of International Classification of Diseases codes for venous thromboembolism in administrative data.

Kristen M Sanfilippo1, Tzu-Fei Wang2, Brian F Gage3, Weijian Liu4, Kenneth R Carson5.   

Abstract

BACKGROUND: Increasingly, clinicians and researchers are using administrative data for clinical and outcomes research. However, they continue to question the accuracy of using International Classification of Diseases 9th Revision (ICD-9) codes alone to capture diagnoses, especially venous thromboembolism (VTE), in administrative data.
OBJECTIVES: We tested the hypothesis that incorporation of treatment data and/or common procedural terminology (CPT) codes could improve accuracy of administrative data in detecting VTE. Research Design Using the Veterans Affairs Central Cancer Registry, we compared three competing algorithms by performing three cross-sectional studies. Algorithm 1 identified patients by ICD-9 codes alone. Algorithm 2 required VTE treatment in addition to ICD-9 codes. Algorithm 3 required a VTE diagnostic CPT code in addition to treatment and ICD-9 criteria.
RESULTS: The accuracy of ICD-9 codes alone for detection of VTE was marginal, with a PPV of 72%. The PPV was improved to 91% after addition of treatment data (algorithm 2). As compared to algorithm 2, addition of CPT codes (algorithm 3) did not significantly increase the accuracy of detecting VTE (PPV 92%), but decreased sensitivity from 72% to 67%.
CONCLUSIONS: Accuracy of VTE detection significantly improved with addition of treatment data to ICD-9 codes. This approach should facilitate use of administrative data to assess the incidence, epidemiology, and outcomes of VTE. Published by Elsevier Ltd.

Entities:  

Keywords:  Administrative data; Health service research; Venous thromboembolism

Mesh:

Year:  2015        PMID: 25613924      PMCID: PMC4361236          DOI: 10.1016/j.thromres.2015.01.012

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  16 in total

1.  Use of subsequent anticoagulants to increase the predictive value of Medicaid deep venous thromboembolism diagnoses.

Authors:  B B Gerstman; J P Freiman; L K Hine
Journal:  Epidemiology       Date:  1990-03       Impact factor: 4.822

Review 2.  A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data.

Authors:  Leonardo Tamariz; Thomas Harkins; Vinit Nair
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01       Impact factor: 2.890

3.  Impact of body mass index on incidence of febrile neutropenia and treatment-related mortality in United States veterans with diffuse large B-cell lymphoma receiving rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone.

Authors:  Arun Ganti; Weijian Liu; Suhong Luo; Kristen M Sanfilippo; Ryan Roop; Ryan Lynch; Peter Riedell; Katiuscia O'Brian; Graham A Colditz; Kenneth R Carson
Journal:  Br J Haematol       Date:  2014-07-15       Impact factor: 6.998

4.  The need to revisit VTE quality measures.

Authors:  Christine V Kinnier; Cindy Barnard; Karl Y Bilimoria
Journal:  JAMA       Date:  2014-07-16       Impact factor: 56.272

Review 5.  Use of databases for clinical research.

Authors:  Yoon K Loke
Journal:  Arch Dis Child       Date:  2014-01-31       Impact factor: 3.791

6.  Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).

Authors:  Lindsay M Morton; Jennifer J Turner; James R Cerhan; Martha S Linet; Patrick A Treseler; Christina A Clarke; Andrew Jack; Wendy Cozen; Marc Maynadié; John J Spinelli; Adele Seniori Costantini; Thomas Rüdiger; Aldo Scarpa; Tongzhang Zheng; Dennis D Weisenburger
Journal:  Blood       Date:  2007-03-27       Impact factor: 22.113

7.  How valid is the ICD-9-CM based AHRQ patient safety indicator for postoperative venous thromboembolism?

Authors:  Richard H White; Banafsheh Sadeghi; Daniel J Tancredi; Patricia Zrelak; Joanne Cuny; Pradeep Sama; Garth H Utter; Jeffrey J Geppert; Patrick S Romano
Journal:  Med Care       Date:  2009-12       Impact factor: 2.983

8.  Clinical validation of the AHRQ postoperative venous thromboembolism patient safety indicator.

Authors:  Katherine E Henderson; Angela j Recktenwald; Richard M Reichley; Thomas C Bailey; Brian M Waterman; Rebecca L Diekemper; Patricia E Storey; Belinda K Ireland; Wm Claiborne Dunagan
Journal:  Jt Comm J Qual Patient Saf       Date:  2009-07

Review 9.  Conducting high-value secondary dataset analysis: an introductory guide and resources.

Authors:  Alexander K Smith; John Z Ayanian; Kenneth E Covinsky; Bruce E Landon; Ellen P McCarthy; Christina C Wee; Michael A Steinman
Journal:  J Gen Intern Med       Date:  2011-02-08       Impact factor: 5.128

10.  Validity of AHRQ patient safety indicators derived from ICD-10 hospital discharge abstract data (chart review study).

Authors:  Hude Quan; Cathy Eastwood; Ceara Tess Cunningham; Mingfu Liu; Ward Flemons; Carolyn De Coster; William A Ghali
Journal:  BMJ Open       Date:  2013-10-10       Impact factor: 2.692

View more
  31 in total

1.  Impact of Inferior Vena Cava Filter Placement on Short-Term Outcomes in Patients with Acute Pulmonary Embolism.

Authors:  Nathan L Liang; Elizabeth A Genovese; Efthymios D Avgerinos; Michael J Singh; Michel S Makaroun; Rabih A Chaer
Journal:  Ann Vasc Surg       Date:  2017-03-23       Impact factor: 1.466

2.  Assessing the accuracy of ICD-10 codes for identifying acute thromboembolic events among patients receiving anticoagulation therapy.

Authors:  Kevin Lawrence; Christopher Joos; Aubrey E Jones; Stacy A Johnson; Daniel M Witt
Journal:  J Thromb Thrombolysis       Date:  2019-08       Impact factor: 2.300

3.  Outcomes associated with observation stays versus inpatient admissions for pulmonary embolism.

Authors:  Erin R Weeda; W Frank Peacock; Gregory J Fermann; Philip S Wells; Veronica Ashton; Concetta Crivera; Thomas J Bunz; Peter Wildgoose; Jeff R Schein; Craig I Coleman
Journal:  J Thromb Thrombolysis       Date:  2016-11       Impact factor: 2.300

4.  Risk of hospitalised bleeding in comparisons of oral anticoagulant options for the primary treatment of venous thromboembolism.

Authors:  Pamela L Lutsey; Neil A Zakai; Richard F MacLehose; Faye L Norby; Rob F Walker; Nicholas S Roetker; Terrence J Adam; Alvaro Alonso
Journal:  Br J Haematol       Date:  2019-03-28       Impact factor: 6.998

5.  Venous Thromboembolism Prophylaxis in Neurocritical Care Patients: Are Current Practices, Best Practices?

Authors:  K M Sauro; A Soo; A Kramer; P Couillard; J Kromm; D Zygun; D J Niven; S M Bagshaw; H T Stelfox
Journal:  Neurocrit Care       Date:  2019-04       Impact factor: 3.210

6.  Incidence of venous thromboembolism in patients with non-Hodgkin lymphoma.

Authors:  K M Sanfilippo; T F Wang; B F Gage; S Luo; P Riedell; K R Carson
Journal:  Thromb Res       Date:  2016-05-11       Impact factor: 3.944

7.  Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.

Authors:  Christine Baumgartner; Alan S Go; Dongjie Fan; Sue Hee Sung; Daniel M Witt; John R Schmelzer; Marc S Williams; Steven H Yale; Jeffrey J VanWormer; Margaret C Fang
Journal:  Thromb Res       Date:  2020-03-05       Impact factor: 3.944

8.  Association of Testosterone Therapy With Risk of Venous Thromboembolism Among Men With and Without Hypogonadism.

Authors:  Rob F Walker; Neil A Zakai; Richard F MacLehose; Logan T Cowan; Terrence J Adam; Alvaro Alonso; Pamela L Lutsey
Journal:  JAMA Intern Med       Date:  2020-02-01       Impact factor: 21.873

9.  Impact of anticoagulant choice on hospitalized bleeding risk when treating cancer-associated venous thromboembolism.

Authors:  N A Zakai; R F Walker; R F MacLehose; T J Adam; A Alonso; P L Lutsey
Journal:  J Thromb Haemost       Date:  2018-10-24       Impact factor: 5.824

10.  Use and Removal of Inferior Vena Cava Filters in Patients With Acute Brain Injury.

Authors:  Kara Melmed; Monica L Chen; Mais Al-Kawaz; Hannah L Kirsch; Andrew Bauerschmidt; Hooman Kamel
Journal:  Neurohospitalist       Date:  2020-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.